Accumold®, a world leader in high-precision micro injection moulding, will exhibit at MD&M East in New York City from May 20–22, 2025. Attendees can visit Booth 551 to discover how Accumold’s advanced micro moulding solutions are enabling the development of next-generation medical devices and components across the healthcare sector.
For more than 40 years, Accumold has specialized in moulding tiny, complex parts that are often impossible to produce using conventional processes. Serving demanding markets such as micro electronics, medical, micro optics, and other emerging technologies, the company is trusted by OEMs worldwide to meet the toughest design challenges and tolerance requirements — often down to just a few microns.
“Our presence at MD&M East reflects our commitment to supporting the rapid evolution of the medical device industry,” says Brett Saddoris, Technical Sales Manager at Accumold. “We thrive on helping engineers and designers turn bold ideas into manufacturable realities — whether they’re prototyping disruptive technologies or ramping up to high-volume production.”
Accumold’s vertically integrated facility in Ankeny, Iowa operates 24/7, bringing together in-house tool design and fabrication, ISO 13485-certified cleanroom moulding, precision metrology, and automated assembly. This seamless integration allows Accumold to offer speed to market, validated scalability, and uncompromising quality — qualities essential for critical medical applications.
Among the company’s latest innovations is its breakthrough in high-volume micro injection moulding of thin-walled cannulas, an achievement five years in the making. Historically produced through extrusion and labor-intensive secondary processes, cannulas with extremely thin walls are now being moulded in a single step — eliminating inconsistencies, improving structural integrity, and enabling annual production volumes of up to 40 million parts per cell.
“The ability to reliably mould cannulas with wall thicknesses as low as 0.004 inches represents a significant leap forward in medical manufacturing,” Saddoris explains. “This process reduces part variability, increases production efficiency, and opens up exciting new design possibilities for minimally invasive medical devices.”
Accumold’s expertise spans a wide range of medical-grade materials including PEEK, LCP, Polycarbonate, Polypropylene, and Pebax. These materials support the creation of bio-compatible, durable components ideal for applications in diagnostics, drug delivery, wearable health tech, and surgical instrumentation.
Visitors to Booth 551 at MD&M East will have the opportunity to meet Accumold’s technical team, view samples of moulded parts, and explore how the company’s micro moulding capabilities can reduce time to market, cut costs, and enable smarter, smaller, and more reliable medical devices.